Cargando…
Mutational analysis of renal angiomyolipoma associated with tuberous sclerosis complex and the outcome of short-term everolimus therapy
To identify clinical characteristics and mutation spectra in Chinese patients with renal angiomyolipoma (AML) associated with the tuberous sclerosis complex (TSC, TSC-AML), examined the efficacy and safety of short-term everolimus therapy (12 weeks). We analyzed the frequency distribution of each TS...
Autores principales: | Ni, Jianxin, Yan, Fengqi, Qin, Weijun, Yu, Lei, Zhang, Geng, Liu, Fei, Yang, Xiaojian, Yang, Bo, Hao, Chunlin, Wang, Teng, Liu, Pengfei, Yuan, Jianlin, Wu, Guojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778095/ https://www.ncbi.nlm.nih.gov/pubmed/31586081 http://dx.doi.org/10.1038/s41598-019-49814-6 |
Ejemplares similares
-
Low-Dose Everolimus Maintenance Therapy for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex
por: Luo, Cong, et al.
Publicado: (2021) -
Adverse Events of Everolimus in Patients with Tuberous Sclerosis Complex Treated for Renal Angiomyolipoma/Subependymal Giant Cell Astrocytoma
por: Gau, Shuo-Yan, et al.
Publicado: (2023) -
Sequential everolimus for angiomyolipoma associated with tuberous sclerosis complex: a prospective cohort study
por: Gu, Liangyou, et al.
Publicado: (2021) -
Individualized everolimus treatment for tuberous sclerosis-related angiomyolipoma promotes treatment adherence and response
por: Chung, Noelle K X, et al.
Publicado: (2022) -
Large renal angiomyolipomas in tuberous sclerosis
por: Esson, G, et al.
Publicado: (2023)